SEATTLE, WA--(Marketwire - Oct 21, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on offering a comprehensive set of innovative, proprietary breast health evaluation products and services that provide accurate and actionable results for personalized cancer prevention and breast health, announced today that Steven C. Quay, M.D., Ph.D., FCAP, Chairman, President & CEO of Atossa Genetics and Director of the National Reference Laboratory for Breast Health, will participate in Active Communications International's 4th National Conference on Next Generation Comprehensive Breast Centers of Excellence, which will take place on October 26-28 in Atlanta, Georgia.
Dr. Quay, along with Dr. Massimo Cristofanilli, Chairman of the Department of Medical Oncology at Fox Chase Cancer Center, will conduct a pre-conference workshop titled "Expanding the Reach of the Breast Cancer Center through Companion Molecular Tests." The workshop, which will take place on Wednesday, October 26, 2011, from 3:00 p.m. to 6:00 p.m., will focus on two topics: 1) Ruling out Breast Cancer at the Annual Gynecology or Breast Clinic Visit; and 2) Reassuring the Breast Cancer Survivor.
"We are proud to be a sponsor of this prestigious annual gathering of representatives from the Breast Centers of Excellence in the U.S.," stated Dr. Quay. "During the pre-conference workshop, we will explain the biology and role of nipple aspirate fluid testing (NAF) and the pathologist's analysis of the test results used prior to imaging in women 20-50 years old, a group not routinely having mammography today. We will also facilitate a discussion about how adding the NAF testing to women ages 50 and over during their annual breast screening will re-assure low risk women of their breast health, even after a negative biopsy and mammography."
About Atossa Genetics, Inc.
Atossa Genetics, Inc. provides a comprehensive set of innovative breast health evaluation products and services that provide accurate and actionable results for personalized cancer prevention and breast health. Atossa has established the National Reference Laboratory for Breast Health, a specially equipped, CLIA-certified laboratory in Seattle, Washington. Patients, health care providers, investors and others seeking information on Atossa and its products and services should visit www.atossagenetics.com.
About the National Reference Laboratory for Breast Health
The National Reference Laboratory for Breast Health, a division of Atossa Genetics, Inc., is focused on developing novel, clinically relevant tests for evaluating Breast Health in all women. The National Reference Laboratory for Breast Health, located in Seattle, Washington, is the only CLIA-registered laboratory focused exclusively on breast health. The National Reference Laboratory for Breast Health provides comprehensive test results to guide personalized breast cancer prevention and treatment solutions. For additional information on the ForeCYTE Breast Health Test and the ArgusCYTE Breast Health Test, please visit www.NRLBH.com.
About the Breast Center of Excellence Designation
The Breast Imaging Center of Excellence (BICOE) designation is awarded to breast imaging centers that achieve excellence by seeking and earning accreditation in all of the American College of Radiology's voluntary breast-imaging accreditation programs and modules, in addition to the mandatory Mammography Accreditation Program. For more information, please visit http://www.acr.org/accreditation/bicoe.aspx.
Contact Information:
Contacts:
Steven C. Quay, M.D., Ph.D., FCAP (Corporate)
Chairman, President and CEO of Atossa Genetics and Director of the National Reference Laboratory for Breast Health
206-325-6086
Matthew D. Haines (Investors and Media)
Managing Director
MBS Value Partners
212-710-9686